Resirene (Tlaxcala, Mexico), the largest polystyrene producer in Mexico, and Foster Corp. (Putnam, CT), a compounder serving healthcare markets, have formed a partnership to pursue the medical market for Resirene’s CET SMMA styrene-acrylic copolymers. Foster will serve as an exclusive distributor for the medical industry in the United States and Canada and leverage its manufacturing capabilities within its core compounding business to provide custom SMMA functionality, including colors, impact modifiers and other specialty enhancements, the company said in a press release. Resirene’s CET SMMA combines the ease of processing of styrene polymers with the crystal clarity of straight acrylic. It also balances rigidity and surface characteristics, while offering chemical resistance, crack resistance and temperature performance not available with SAN or PMMA. Several biocompatible CET SMMA grades are available for healthcare applications .
“We have already seen some successes in the medical segment for our CET SMMA material,” said Moises Romero Manig, Market Development & Business Intelligence Manager at Resirene. “With Foster’s expertise in this segment, we are confident that this collaboration will help to accelerate our growth here.”
Larry Johnson, Executive Vice President for Foster Corp., added: “Our current customers and prospects serving the medical segment are always looking for new transparent material options that can help them to meet the performance requirements and regulatory approvals while contributing to cost-savings initiatives. We’re proud to bring Resirene’s CET SMMA into our portfolio of solutions.”